Wednesday, February 12, 2025 8:33:32 AM
Ticker: NXU. 600 Billion Market Merge just Approved! Moon
Recent APTOF News
- Form SC 13E3/A - Going private transaction by certain issuers: [Amend] • Edgar (US Regulatory) • 04/01/2026 08:14:53 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 09:29:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 09:23:27 PM
- Aptose Biosciences Announces Results of Special Shareholders Meeting; Announces Receipt of Final Court Approval of Plan of Arrangement; Reports Year End 2025 Results and Corporate Highlights • GlobeNewswire Inc. • 03/31/2026 09:22:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 08:59:27 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 03/23/2026 09:15:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 09:02:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 11:30:11 AM
- Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan of Arrangement • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/19/2026 11:40:10 AM
- Leading Independent Proxy Advisory Firm ISS Recommends Aptose Biosciences Shareholders Vote “FOR” Proposed Plan of Arrangement with Hanmi Pharmaceutical • GlobeNewswire Inc. • 03/19/2026 11:30:00 AM
- Aptose Biosciences Announces Amendment to Arrangement Agreement and Details of Postponed Special Meeting of Shareholders • GlobeNewswire Inc. • 02/24/2026 12:00:00 PM
- Form SC 13E3/A - Going private transaction by certain issuers: [Amend] • Edgar (US Regulatory) • 02/17/2026 11:13:46 AM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 02/17/2026 11:06:40 AM
- Form SC 13E3/A - Going private transaction by certain issuers: [Amend] • Edgar (US Regulatory) • 02/09/2026 11:15:56 AM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 02/09/2026 11:06:31 AM
- Form SC 13E3 - Going private transaction by certain issuers • Edgar (US Regulatory) • 01/15/2026 02:26:21 AM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 01/15/2026 02:23:33 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2025 10:16:17 PM
- Aptose Biosciences Announces Rescheduling of Special Meeting of Shareholders to Approve the Acquisition by Hanmi Pending Final Clearance from SEC • GlobeNewswire Inc. • 12/19/2025 10:05:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2025 12:15:26 PM
- Aptose’s Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations • GlobeNewswire Inc. • 12/06/2025 01:00:00 PM
- Form PREM14A - Preliminary proxy statements relating to merger or acquisition • Edgar (US Regulatory) • 12/05/2025 09:08:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/19/2025 11:02:30 AM
- Aptose Biosciences Announces Arrangement Agreement for Acquisition by Hanmi Pharmaceutical • GlobeNewswire Inc. • 11/19/2025 06:22:25 AM
